Safety and Efficacy of the Combo Bio-engineered Sirolimus-eluting Stent Versus the Nano Polymer-free Sirolimus-eluting Stent in the Treatment of Patients With de Novo Stenotic Lesions
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 440 participants.
Also called NCT02542007
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 440 participants
- Registry
-
NCT02542007
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT02542007. Randomized; no masking; primary purpose treatment. Start 2015-05 (registry gives no type); primary completion 2017-05-27 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy of the Combo Bio-engineered Sirolimus-eluting Stent Versus the Nano Polymer-free Sirolimus-eluting Stent in the Treatment of Patients With de Novo Stenotic Lesions
- Acronym
- RECOVERY
- Condition
- Coronary Arteriosclerosis
- Intervention (Device)
- OrbusNeich Combo stent™
- Intervention (Device)
- sirolimus-eluting stent system
- Lead sponsor
- OrbusNeich
- Collaborator
- CCRF Inc., Beijing, China
- Collaborator
- OrbusNeich Medical (Shenzhen), Co. Ltd.
Record details
- Record id
cardio:ct-nct02542007- Content hash
a272d62ae85fe9e5c274a70b13228c75dcdf5d572bbb8908c32edc9d4df2f15e